245 related articles for article (PubMed ID: 15497179)
1. Sensitive in vitro test systems to determine androgenic/antiandrogenic activity.
Guth SE; Böhm S; Mussler BH; Eisenbrand G
Mol Nutr Food Res; 2004 Sep; 48(4):282-91. PubMed ID: 15497179
[TBL] [Abstract][Full Text] [Related]
2. Androgen receptor activities of p,p'-DDE, fenvalerate and phoxim detected by androgen receptor reporter gene assay.
Xu LC; Sun H; Chen JF; Bian Q; Song L; Wang XR
Toxicol Lett; 2006 Jan; 160(2):151-7. PubMed ID: 16125883
[TBL] [Abstract][Full Text] [Related]
3. Partial agonist/antagonist properties of androstenedione and 4-androsten-3beta,17beta-diol.
Chen F; Knecht K; Leu C; Rutledge SJ; Scafonas A; Gambone C; Vogel R; Zhang H; Kasparcova V; Bai C; Harada S; Schmidt A; Reszka A; Freedman L
J Steroid Biochem Mol Biol; 2004 Aug; 91(4-5):247-57. PubMed ID: 15336702
[TBL] [Abstract][Full Text] [Related]
4. Human reporter gene assays: transcriptional activity of the androgen receptor is modulated by the cellular environment and promoter context.
Simon S; Mueller SO
Toxicology; 2006 Mar; 220(2-3):90-103. PubMed ID: 16413649
[TBL] [Abstract][Full Text] [Related]
5. Dicofol degradation to p,p'-dichlorobenzophenone - a potential antiandrogen.
Thiel A; Guth S; Böhm S; Eisenbrand G
Toxicology; 2011 Apr; 282(3):88-93. PubMed ID: 21291947
[TBL] [Abstract][Full Text] [Related]
6. Development of androgen- and estrogen-responsive bioassays, members of a panel of human cell line-based highly selective steroid-responsive bioassays.
Sonneveld E; Jansen HJ; Riteco JA; Brouwer A; van der Burg B
Toxicol Sci; 2005 Jan; 83(1):136-48. PubMed ID: 15483189
[TBL] [Abstract][Full Text] [Related]
7. Suppression of mutant androgen receptors by flutamide.
Ishioka J; Hara S; Isaacs JT; Tomura A; Nishikawa K; Kageyama Y
Int J Urol; 2009 May; 16(5):516-21. PubMed ID: 19389135
[TBL] [Abstract][Full Text] [Related]
8. Screening of some anti-androgenic endocrine disruptors using a recombinant cell-based in vitro bioassay.
Roy P; Salminen H; Koskimies P; Simola J; Smeds A; Saukko P; Huhtaniemi IT
J Steroid Biochem Mol Biol; 2004 Feb; 88(2):157-66. PubMed ID: 15084347
[TBL] [Abstract][Full Text] [Related]
9. Decoy androgen-responsive element DNA can inhibit androgen receptor transactivation of the PSA promoter gene.
Zhang P; Zhang J; Young CY; Kao PC; Chen W; Jiang A; Zhang L; Guo Q
Ann Clin Lab Sci; 2005; 35(3):278-84. PubMed ID: 16081584
[TBL] [Abstract][Full Text] [Related]
10. Steroid hormonal regulation of growth, prostate specific antigen secretion, and transcription mediated by the mutated androgen receptor in CWR22Rv1 human prostate carcinoma cells.
Attardi BJ; Burgenson J; Hild SA; Reel JR
Mol Cell Endocrinol; 2004 Jul; 222(1-2):121-32. PubMed ID: 15249132
[TBL] [Abstract][Full Text] [Related]
11. Curcumin blocks the activation of androgen and interlukin-6 on prostate-specific antigen expression in human prostatic carcinoma cells.
Tsui KH; Feng TH; Lin CM; Chang PL; Juang HH
J Androl; 2008; 29(6):661-8. PubMed ID: 18676361
[TBL] [Abstract][Full Text] [Related]
12. Antiandrogenic activity of norgestimate in a human androgen-dependent stable-transfected cell line.
Paris F; Rabeolina F; Balaguer P; Bacquet A; Sultan C
Gynecol Endocrinol; 2007 Apr; 23(4):193-7. PubMed ID: 17505938
[TBL] [Abstract][Full Text] [Related]
13. Effects of 2,4-D and DCP on the DHT-induced androgenic action in human prostate cancer cells.
Kim HJ; Park YI; Dong MS
Toxicol Sci; 2005 Nov; 88(1):52-9. PubMed ID: 16107550
[TBL] [Abstract][Full Text] [Related]
14. Effect of bisphenol A, tetrachlorobisphenol A and pentachlorophenol on the transcriptional activities of androgen receptor-mediated reporter gene.
Sun H; Xu LC; Chen JF; Song L; Wang XR
Food Chem Toxicol; 2006 Nov; 44(11):1916-21. PubMed ID: 16893599
[TBL] [Abstract][Full Text] [Related]
15. Development of two androgen receptor assays using adenoviral transduction of MMTV-luc reporter and/or hAR for endocrine screening.
Hartig PC; Bobseine KL; Britt BH; Cardon MC; Lambright CR; Wilson VS; Gray LE
Toxicol Sci; 2002 Mar; 66(1):82-90. PubMed ID: 11861975
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of androgen receptor-dependent transcriptional activity by DDT isomers and methoxychlor in HepG2 human hepatoma cells.
Maness SC; McDonnell DP; Gaido KW
Toxicol Appl Pharmacol; 1998 Jul; 151(1):135-42. PubMed ID: 9705896
[TBL] [Abstract][Full Text] [Related]
17. Coexpression of the partial androgen receptor enhances the efficacy of prostate-specific antigen promoter-driven suicide gene therapy for prostate cancer cells at low testosterone concentrations.
Suzuki S; Tadakuma T; Asano T; Hayakawa M
Cancer Res; 2001 Feb; 61(4):1276-9. PubMed ID: 11245419
[TBL] [Abstract][Full Text] [Related]
18. The CCK-2/gastrin splice variant receptor retaining intron 4 transactivates the COX-2 promoter in vitro.
Huang H; Ansorge N; Schrader H; Banasch M; Yu HG; Schmidt WE; Höcker M; Schmitz F
Regul Pept; 2007 Dec; 144(1-3):34-42. PubMed ID: 17936921
[TBL] [Abstract][Full Text] [Related]
19. Screening for (anti)androgenic properties using a standard operation protocol based on the human stably transfected androgen sensitive PALM cell line. First steps towards validation.
Freyberger A; Witters H; Weimer M; Lofink W; Berckmans P; Ahr HJ
Reprod Toxicol; 2010 Aug; 30(1):9-17. PubMed ID: 19836445
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the rodent Hershberger bioassay: testing of coded chemicals and supplementary molecular-biological and biochemical investigations.
Freyberger A; Ellinger-Ziegelbauer H; Krötlinger F
Toxicology; 2007 Sep; 239(1-2):77-88. PubMed ID: 17688994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
